Eva S. Thomas
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Oncology top 2%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
Papers in
-
- Breast Cancer Treatment Studies 9
- Oncology 11
- Cancer Treatment and Pharmacology 8
- COVID-19 and healthcare impacts 1
- Pancreatic and Hepatic Oncology Research 1
- HER2/EGFR in Cancer Research 1
- Co-authors
- Gabriel N. Hortobágyi (8 shared papers)Aman U. Buzdar (6 shared papers)Richard L. Theriault (4 shared papers)Thomas A. Buchholz (5 shared papers)S. Eva Singletary (4 shared papers)Nuhad K. Ibrahim (3 shared papers)Linda T. Vahdat (6 shared papers)Marjorie C. Green (3 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Clinical Breast Cancer (3 papers)Cancer (2 papers)Supportive Care in Cancer (1 paper)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- United StatesFranceSouth Korea
In The Last Decade
Eva S. Thomas
20 papers receiving 2.5k citations
Eva S. Thomas's Hit Papers
Peers
Comparison fields: 5 of 61
- Cancer Research 1.2k
- Oncology 1.4k
- Pathology and Forensic Medicine 87
- Pulmonary and Respiratory Medicine 149
- Radiology, Nuclear Medicine and Imaging 104
Countries citing papers authored by Eva S. Thomas
This map shows the geographic impact of Eva S. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva S. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva S. Thomas more than expected).
Fields of papers citing papers by Eva S. Thomas
This network shows the impact of papers produced by Eva S. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva S. Thomas. The network helps show where Eva S. Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva S. Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer Hit paper breakdown → | 2005 | 956 |
| 2 | 2008 | 393 | |
| 3 | 2007 | 332 | |
| 4 | 2007 | 246 | |
| 5 | 2003 | 150 | |
| 6 | Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial. | 2002 | 131 |
| 7 | 2004 | 120 | |
| 8 | 2004 | 51 | |
| 9 | 2008 | 50 | |
| 10 | 2004 | 41 | |
| 11 | 2012 | 37 | |
| 12 | 2012 | 31 | |
| 13 | 2018 | 31 | |
| 14 | 2022 | 24 | |
| 15 | 2009 | 21 | |
| 16 | 2012 | 9 | |
| 17 | 1998 | 8 | |
| 18 | 2006 | 8 | |
| 19 | 2022 | 4 | |
| 20 | 2023 | 1 |
About Eva S. Thomas
Eva S. Thomas is a scholar working on Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health, having authored 20 papers that have together received 2.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (9 papers), Cancer Treatment and Pharmacology (8 papers), Telemedicine and Telehealth Implementation (1 paper), Lung Cancer Diagnosis and Treatment (1 paper), COVID-19 and healthcare impacts (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Effects of Radiation Exposure (1 paper) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.4k citations), Pathology and Forensic Medicine (87 citations), Pulmonary and Respiratory Medicine (149 citations) and Radiology, Nuclear Medicine and Imaging (104 citations). Eva S. Thomas has collaborated with scholars based in United States, France and South Korea. Frequent co-authors include Gabriel N. Hortobágyi, Aman U. Buzdar, Richard L. Theriault, Thomas A. Buchholz, S. Eva Singletary, Nuhad K. Ibrahim, Linda T. Vahdat, Marjorie C. Green, Terry L. Smith and Debra K. Frye. Their work appears in journals such as Journal of Clinical Oncology, Clinical Breast Cancer, Cancer, Supportive Care in Cancer and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.